All GSK articles – Page 4

Feature
The hunt for innovation

2014-01-31T00:00:00Z

Big pharma companies are embracing a more open and collaborative approach. Nuala Moran discovers who’s working with whom
Business
Weathering the storm

2014-01-06T00:00:00Z

Pharmaceutical industry roundup 2013
Business
US turnaround on Avandia restrictions

2013-12-02T00:00:00Z

Researchers accuse regulator of face-saving U-turn over diabetes medication safety
Business
Pfizer teams up with GSK in cancer drug trial

2013-11-25T00:00:00Z

Two companies will collaborate to develop a combination therapy for melanoma
Business
GSK forms Brazilian sustainable chemistry venture

2013-10-29T00:00:00Z

Agreement with research organisation will launch centre for greener, cleaner drug production
Business
GSK to apply for malaria vaccine approval

2013-10-09T00:00:00Z

Infection protection drops over time, but the firm will go ahead with regulatory submission
Business
Aspen acquires anticoagulant brands

2013-10-02T00:00:00Z

South African drugmaker buys thrombosis drugs from GSK for £700m
Business
New respiratory drugs neck and neck

2013-09-25T00:00:00Z

Combination inhalers from GSK and Novartis approved in EU and Japan
Business
GSK criticised for trial data secrecy

2013-09-17T00:00:00Z

Italian research institute abandons collaboration over data access
Business
GSK divests Lucozade and Ribena brands

2013-09-10T00:00:00Z

£1.35 billion deal allows GSK to focus on pharma business
Business
Couple charged in GSK corruption investigation

2013-08-29T00:00:00Z

Two private investigators have been charged with breaching the privacy rights of Chinese citizens
Business
India revokes more pharma patents

2013-08-02T00:00:00Z

Original molecule patent stands, but a new salt form is ‘not innovative’
Business
China corruption investigation broadens

2013-07-29T00:00:00Z

GSK scandal is the trigger to clean up Chinese drug market
Business
GSK under investigation over corruption in China

2013-07-12T00:00:00Z

Police claim executives engaged in bribery and tax-related crimes
Business
Aspen in $1 billion deal with Merck & Co

2013-07-01T00:00:00Z

South African generics manufacturer to buy 11 drug brands and an API business from the US drugmaker
Business
GSK fires Chinese R&D head in data investigation

2013-06-14T00:00:00Z

Company is retracting a 2010 study in which data were ‘misrepresented’
Business
Two new ‘personalised’ cancer drugs approved

2013-05-31T00:00:00Z

Suitable patients for GSK’s melanoma treatments must be identified using an accompanying genetic test
Business
GSK partners Save the Children for Africa project

2013-05-16T00:00:00Z

Company and charity will work together to provide medicines for the developing world
Business
Objections raised to GSK pay-for-delay deals

2013-04-19T00:00:00Z

The UK Office of Fair Trading believes deals to delay generic drugs infringed competition laws
News
Phenome centre move ends GSK role

2013-01-08T00:00:00Z

‘Olympic legacy’ centre to shift to dedicated Imperial College Hammersmith Hospital facility